Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
8f:10m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
3.36×10-06
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0739
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.611
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
8f:10m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.356
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Triglycerides
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.277
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.227
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
8f:10m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
6.15×10-26
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
1.36×10-18
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.538
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0403
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
1.20×10-11
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.653
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HOM
|
180f:348m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
180f:348m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
35f:10m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
f:15m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0249
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.166
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00977
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.795
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.854
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
1.28×10-08
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
DEXA / Fat/Body weight
|
HOM
|
7f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
9.98×10-06
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
1.07×10-06
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0244
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
1.38×10-05
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
DEXA / Fat mass
|
HOM
|
7f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.598
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Calorimetry / Carbon dioxide production
|
HOM
|
f:405m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
4f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.429
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.847
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.555
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Calorimetry / Oxygen consumption
|
HOM
|
f:405m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.221
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:405m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00615
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.595
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.162
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.367
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.124
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0956
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0962
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.853
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.164
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.159
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.227
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
4f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0187
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.532
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.486
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.173
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
2.35×10-06
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
1.38×10-05
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00214
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.227
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
2.23×10-06
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Calorimetry / Cumulative food intake
|
HOM
|
f:405m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.448
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.882
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.739
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0205
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.327
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0811
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.000189
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.892
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0823
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0149
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.285
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0365
|
Successful |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Dysmorphology / Body fat distribution
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
120f:348m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Gys2tm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.115
|
Successful |